黄体生成素、卵泡刺激素及LH/FSH比值在多囊卵巢综合征中的研究进展
Research Progress of Luteinizing Hormone, Follicle-Stimulating Hormone and LH/FSH Ratio in Polycystic Ovary Syndrome
摘要: 多囊卵巢综合征(PCOS)是一种由于糖代谢异常与内分泌失调引发的以高雄激素血症、稀发排卵或无排卵、胰岛素抵抗、超重或肥胖、月经不规则等为特征的一种生殖内分泌性疾病,是困扰育龄期女性难孕难育、不孕不育的重要原因之一;其中黄体生成素(LH)、卵泡刺激素(FSH)作为性激素轴中与卵巢功能密切相关的激素,在多囊卵巢综合征(PCOS)中有异于生理状态的改变,可能呈现出黄体生成素(LH)水平升高、卵泡刺激素(FSH)水平不变或降低及LH/FSH比值升高的情况;所以目前大部分研究看来黄体生成素(LH)、卵泡刺激素(FSH)及LH/FSH比值是研究甚至是诊断多囊卵巢综合征(PCOS)的重要指标,此综述总结了目前多囊卵巢综合征(PCOS)中黄体生成素(LH)、卵泡刺激素(FSH)及LH/FSH比值等指标的研究进展。
Abstract: Polycystic ovary syndrome (PCOS) is a reproductive endocrine disease caused by abnormal glucose metabolism and endocrine disorders, which is characterized by hyperandrogenism, rare ovulation or anovulation, insulin resistance, overweight or obesity, irregular menstruation, etc. It is one of the important reasons that plague women of childbearing age who are difficult to conceive, have chil-dren and have infertility. Among them, Luteinizing hormone (LH) and follicle stimulating hormone (FSH), which are closely related to ovarian function in the sex hormone axis, have different changes from the physiological state in polycystic ovary syndrome (PCOS), which may show the situation that the level of luteinizing hormone (LH) is increased, the level of follicle stimulating hormone (FSH) is unchanged or decreased, and the ratio of LH/FSH is increased. Therefore, it seems that luteinizing hormone (LH), follicle stimulating hormone (FSH) and LH/FSH ratio are important indicators for studying and even diagnosing polycystic ovary syndrome (PCOS). This review summarizes the re-search progress of luteinizing hormone (LH), follicle stimulating hormone (FSH) and LH/FSH ratio in polycystic ovary syndrome (PCOS).
文章引用:刘清, 刘东方. 黄体生成素、卵泡刺激素及LH/FSH比值在多囊卵巢综合征中的研究进展[J]. 临床医学进展, 2023, 13(4): 5938-5943. https://doi.org/10.12677/ACM.2023.134839

参考文献

[1] 张蓓, 魏薇, 杨璨. AMH、DHEA-S、LH、FSH在多囊卵巢综合征患者血清中的表达及临床意义[J]. 贵州医药, 2022, 46(1): 126-127.
[2] Bosch, E., et al. (2021) Reduced FSH and LH Action: Implications for Medically Assisted Reproduction. Human Reproduction, 36, 1469-1480. [Google Scholar] [CrossRef] [PubMed]
[3] Le, M.T., et al. (2019) Exploration of the Role of Anti-Mullerian Hormone and LH/FSH Ratio in Diagnosis of Polycystic Ovary Syn-drome. Clinical Endocrinology, 90, 579-585. [Google Scholar] [CrossRef] [PubMed]
[4] Blank, S.K., McCartney, C.R. and Marshall, J.C. (2006) The Origins and Sequelae of Abnormal Neuroendocrine Function in Polycystic Ovary Syn-drome. Human Reproduction Update, 12, 351-361. [Google Scholar] [CrossRef] [PubMed]
[5] Gross, K.M., Matsumoto, A.M. and Bremner, W.J. (1987) Differen-tial Control of Luteinizing Hormone and Follicle- Stimulating Hormone Secretion by Luteinizing Hormone-Releasing Hormone Pulse Frequency in Man. The Journal of Clinical Endocrinology and Metabolism, 64, 675-680. [Google Scholar] [CrossRef] [PubMed]
[6] 张红阳, 侯丽辉. 多囊卵巢综合征患者LH/FSH比值与临床及生化水平的相关性[J]. 医学研究杂志, 2019, 48(6): 64-67.
[7] 宋美杉, 连方. 基础LH/FSH比值对多囊卵巢综合征患者IVF-ET妊娠结局的影响[J]. 中国临床研究, 2021, 34(6): 774-776.
[8] 杨明明, 马生秀. 多囊卵巢综合征LH/FSH的特点以及其他临床指标的相关性[J]. 世界最新医学信息文摘, 2017, 17(68): 64-65.
[9] Marcondes, J.A., et al. (2007) Metformin in Normal-Weight Hirsute Women with Polycystic Ovary Syndrome with Normal Insulin Sensitivity. Gynecological Endocrinology, 23, 273-278. [Google Scholar] [CrossRef] [PubMed]
[10] Dumesic, D.A., et al. (2015) Scientific Statement on the Diag-nostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocrine Re-views, 36, 487-525. [Google Scholar] [CrossRef] [PubMed]
[11] Woo, I., et al. (2015) Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome. The Journal of Reproductive Medicine, 60, 495-500.
[12] 杨元松. 血清FSH、LH、TSTO在多囊卵巢综合征患者中的表达及意义[J]. 实用妇科内分泌电子杂志, 2015, 2(3): 32-33.
[13] 岑振考, 叶恒君. 探讨多囊卵巢综合征患者检测血清LH、FSH、TSTO的意义[J]. 中国现代药物应用, 2015, 9(12): 29-30.
[14] 陈进萍. 血清FSH、LH、TSTO水平变化对多囊卵巢综合征不孕患者的临床价值[J]. 临床医学工程, 2017, 24(6): 811-812.
[15] 胡艳军, 杨永妮. 多囊卵巢综合征患者血清FSH、LH、睾酮检测的临床意义[J]. 包头医学院学报, 2016, 32(7): 92-93.
[16] 刘红霞. LH/FSH比值对多囊卵巢综合征的诊断价值分析[J]. 深圳中西医结合杂志, 2016, 26(8): 60-61.
[17] 潘莉娜. 血清黄体生成素与卵泡刺激素比值及雄激素受体基因多态性与多囊卵巢关系的探讨[J]. 贵州医药, 2018, 42(7): 774-776.
[18] 梅园园, 彭璇, 张小芬. 94例多囊卵巢综合征患者代谢特征观察[J]. 南昌大学学报(医学版), 2010, 50(7): 55-57.
[19] 刘雪连. 多囊卵巢综合症患者血浆leptin和血清T、E2、FSH、LH、PRL水平检测的临床意义[J]. 医学信息(中旬刊), 2011, 24(8): 3912-3913.
[20] Kumar, N. and Agarwal, H. (2022) Early Clinical, Biochemical and Radiological Features in Obese and Non-Obese Young Women with Polycystic Ovarian Syndrome: A Comparative Study. Hormone and Metabolic Re-search, 54, 620- 624. [Google Scholar] [CrossRef] [PubMed]
[21] Souza Dos Santos, A. (2015) The Impact of Body Mass on Inflammatory Markers and Insulin Resistance in Polycystic Ovary Syndrome. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 31, 225-228. [Google Scholar] [CrossRef] [PubMed]
[22] Mor, E., et al. (2004) The Insulin Resistant Subphenotype of Polycystic Ovary Syndrome: Clinical Parameters and Pathogenesis. American Journal of Obstetrics and Gynecology, 190, 1654-1660. [Google Scholar] [CrossRef] [PubMed]
[23] 周小静. 不同LH/FSH水平下PCOS患者的糖脂代谢特点及其中医证候分布规律的研究[D]: [硕士学位论文]. 兰州: 甘肃中医药大学, 2022.
[24] 王芳. 多囊卵巢综合征不孕患者血清HSP70、FSH、LH水平及与脂代谢关系[J]. 中国计划生育学杂志, 2022, 30(7): 1617-1620.
[25] Banaszewska, B., et al. (2003) Incidence of Elevated LH/FSH Ratio in Polycystic Ovary Syndrome Women with Normo-and Hyperinsulinemia. Roczniki Akademii Medycznej w Bialymstoku, 48, 131-134.
[26] Saadia, Z. (2020) Follicle Stimulating Hormone (LH:FSH) Ratio in Polycystic Ovary Syndrome (PCOS)—Obese vs. Non-Obese Women. Medical Archives, 74, 289-293. [Google Scholar] [CrossRef] [PubMed]
[27] Esmaeilzadeh, S., et al. (2014) Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate with Clinical Symptoms among Women with Polycystic Ovary Syndrome. Global Journal of Health Science, 7, 101-106. [Google Scholar] [CrossRef] [PubMed]
[28] 葛蕾. AMH、LH/FSH对多囊卵巢综合征患者的预测价值[J]. 中外医学研究, 2021, 19(2): 88-90.
[29] 谭健. AMH、LH、FSH对多囊卵巢综合征的诊断价值[J]. 实用妇科内分泌电子杂志, 2020, 7(6): 122-130.
[30] Yanagihara, R. (2023) Compatible Cut-Off Values for Luteinizing Hormone and the Luteinizing Hormone/Follicle- Stimulating Hormone Ratio in Diagnostic Criteria of the Japan Society of Obstetrics and Gynecology for Polycystic Ovary Syndrome. The Journal of Obstetrics and Gynaecology Research, 49, 253-264. [Google Scholar] [CrossRef] [PubMed]
[31] Beydoun, H.A., et al. (2012) Relationship of Obesity-Related Disturbances with LH/FSH Ratio among Post-Meno- pausal Women in the United States. Maturitas, 71, 55-61. [Google Scholar] [CrossRef] [PubMed]